Electrode features for hearing preservation and drug delivery strategies

Cochlear Implants and Hearing Preservation

Volumn 67, Issue , 2009, Pages 28-42

  Jolly, Claude ^a   Garnham, C ^a   Mirzadeh, H ^b   Truy, E ^c,d   Martini, A ^e   Kiefer, J ^f   Braun, S ^g  

^a MED EL GmbH   (Austria)

^b IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

^c UNIVERSITÉ LYON 1   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITY OF FERRARA   (Italy)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AUDITION; CELL DEATH; COCHLEAR IMPLANTS; ELECTRODES; TARGETED DRUG DELIVERY;

APOPTOSIS INHIBITORS; CLINICAL APPLICATION; DEVICE OPTIMIZATION; DRUG DELIVERY STRATEGIES; FLEXIBLE ELECTRODE ARRAYS; HEARING PRESERVATION; LABORATORY EVALUATION; LEVELS OF PROTECTIONS;

CONTROLLED DRUG DELIVERY;

EID: 84861332703     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000262594     Document Type: Chapter

References (33)

1. Adunka O, Kiefer J, Unkelbach MH, Lehnert T, Gstoettner W: Development and evaluation of an improved cochlear implant electrode design for electric acoustic stimulation. Laryngoscope 2004;114:1237-1241.
2. Gantz BJ, Turner C, Gfeller KE: Acoustic plus electric speech processing: preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant. Audiol Neurootol 2006;11(Suppl 1):63-68.
3. Lenarz T, Stover T, Buechner A, Paasche G, Briggs R, Risi F, Pesch J, Battmer RD: Temporal bone results and hearing preservation with a new straight electrode. Audiol Neurootol 2006;(11 Suppl 1):34-41.
4. Kessler M: Cochlear Implant Hybrids: Who Is a Candidate? You May Be Surprised. http://www.audiologyonline.com/articles/pf_article_detail.asp?article_id=1546 (March 20, 2006).
5. Aschendorff A, Kromeier J, Klenzner T, Laszig R: Quality control after insertion of the nucleus contour and contour advance electrode in adults. Ear Hear 2007;28(2 Suppl):75S-79S.
6. Rebscher SJ, Hetherington A, Bonham B, Wardrop P, Whinney D, Leake PA: Considerations for design of future cochlear implant electrode arrays: electrode array stiffness, size, and depth of insertion. J Rehabil Res Dev 2008;45:731-747.
7. Adunka OF, Radeloff A, Gstoettner WK, Pillsbury HC, Buchman CA: Scala tympani cochleostomy. II. Topography and histology. Laryngoscope 2007;117:2195-2200.
8. Roland PS, Wright CG: Surgical aspects of cochlear implantation: mechanisms of insertional trauma. Adv Otorhinolaryngol 2006;64:11-30.
9. Roland PS, Wright CG, Isaacson B: Cochlear implant electrode insertion: the round window revisited. Laryngoscope 2007;117:1397-1402.
10. Linder T, Schlegel C, DeMin N, van der Westhuizen S: Active middle ear implants in patients undergoing subtotal petrosectomy: new application for the Vibrant Soundbridge device and its implication for lateral cranium base surgery. Otol Neurotol 2009;30:41-47.
11. Eshraghi A, Jolly C, Balkany T: Smallfenestra cochleostomy for MED-EL electrode. Cochlear Implants Int 2004;5:71-75.
12. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272-280.
13. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR: Blocking c-Jun-Nterminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 2007;226:168-177.
14. Choi CH, Oghalai JS: Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hear Res 2005;205:193-200.
15. Radeloff A, Unkelbach MH, Tillein J, Braun S, Helbig S, Gstöttner W, Adunka OF: Impact of intrascalar blood on hearing. Laryngoscope 2007;117:58-62.
16. Baumgartner WD, Jappel A, Morera C, Gstöttner W, Müller J, Kiefer J, Van De Heyning P, Anderson I, Nielsen SB: Outcomes in adults implanted with the FLEXsoft electrode. Acta Otolaryngol 2007;127:579-586.
17. Skarzyński H, Lorens A, D'Haese P, Walkowiak A, Piotrowska A, Sliwa L, Anderson I: Preservation of residual hearing in children and post-lingually deafened adults after cochlear implantation: an initial study. ORL J Otorhinolaryngol Relat Spec 2002;64:247-253.
18. Gstoettner WK, Helbig S, Maier N, Kiefer J, Radeloff A, Adunka OF: Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiol Neurootol 2006;11(Suppl 1):49-56.
19. Forge A, Van de Water T: Protection and repair of inner ear sensory cells; in Salvi RJ, Popper AN, Fay RR (eds): Hair Cell Regeneration, Repair, and Protection. Springer Handbook of Auditory Research. New York, Springer, 2008, pp 199-256.
20. Eshraghi AA, Van de Water TR: Cochlear implantation trauma and noise-induced hearing loss: apoptosis and therapeutic strategies. Anat Rec A Discov Mol Cell Evol Biol 2006;288:473-481.
21. Keithley EM, Wang X, Barkdull G: Tumour necrosis factor alpha can induce recruitment of inflammatory cells to the cochlea. Otol Neurotol 2008;29:854-859.
22. Dinh CT, Haake S, Chen S, Hoang K, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR: Dexamethasone protects organ of Corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosis-related genes. Neuroscience 2008;157:405-413.
23. Eshraghi AA, Adil E, He J, Graves R, Balkany TJ, Van De Water TR: Local dexamethasone therapy conserves hearing in an animal model of electrode insertion trauma-induced hearing loss. Otol Neurotol 2007;28:842-849.
24. Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J: Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear 2007;28:361-369.
25. James DP, Eastwood H, Trichardson R, O'Leary SJ: Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurotol 2008;13:86-96.
26. Vivero RJ, Joseph DE, Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van de Water TR: Dexamethasone base conserves hearing from electrode traumainduced hearing loss. Laryngoscope 2008;118:2028-2033.
27. Kiefer J, Liu Y, Fauser C, Jolly C, Schneider H, Steinhof J, Ebenhoch H, Muller J, Lohner A, Hauber K, Arnold W: Elution of dexamethasone from a cochlear implant. Release profiles and efficacy evaluation. 45th Inner Ear Biol Workshop, Ferrara, September 2008.
28. Barkdull GC, Hondarrague Y, Meyer T, Harris JP, Keithley EM: AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis. Laryngoscope 2007;117:2174-2182.
29. Garnham C, Reetz G, Jolly C, Miller J, Salt A, Beal F: Drug delivery to the cochlea after implantation: consideration of the risk factors. Proceedings of the 4th International Symposium on Electronic Implants in Otology and Conventional Hearing Aids. Cochlear Implants Int 2005;6(Suppl 1):12-14.
30. Salt A, Ma Y: Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001;154:88-97.
31. Farahmand F, Mirzadeh H, Imani M, Jolly C, Farhadi M: Corticosteroid releasing cochlear implant: a novel hybrid of biomaterial and drug delivery system. J Biomed Mater Res A, submitted.
32. Paasche G, Bockel F, Tasche C, Lesinski-Schiedat A, Lenarz T: Changes of postoperative impedances in cochlear implant patients: the short-term effects of modified electrode surfaces and intracochlear corticosteroids. Otol Neurotol 2006;27:639-647.
33. Wysocki J: Dimensions of the human vestibular and tympanic scalae. Hear Res 1999;135:39-46.